The FACS plots in the original Fig. 1b were obtained from the ROSA26 cell line also used for the blastocyst injection studies and the postnatal transplantation in NOD-SCID mice. In Fig. 1 we now provide additional FACS analysis data for these specific antigens from the GFP transduced mouse MAPC line we described in the original Article at population doubling 120 (this line was also used to demonstrate the single-cell origin of endothelium-like, hepatocytelike and neuroectoderm-like cell differentiation in vitro). These data appear not to be subject to the same technical problem. On the basis of this analysis, we have summarized the FACS phenotype of MAPC in Table 1 below. The phenotype of MAPC isolated subsequently and published by our group 1,2 are also not affected by the same flaws in the plots published in the original Article. It should also be noted that ) (mIgG2a); CD19, and Sca-1 (rIgG2a); Gr-1, Mac-1, CD3, CD44, CD45, Thy-1 and c-Kit (rIgG2b); CD13 (rIgG1); or with an unconjugated IgG2a antibody directed at CD34 or Flk-1 followed by a secondary PE-coupled antibody. For each sample an individual tube of cells was stained with a control IgG antibody of the correct IgG subtype either directly coupled to PE, or followed by a secondary PE-coupled antibody. All antibodies were from Becton Dickinson. For SSEA-1, ROSA26 mousederived MAPC were collected after 120 population doublings and stained with an unconjugated anti-SSEA-1 antibody (mIgM, obtained from Iowa Hybridoma Bank) followed by a FITC-coupled secondary antibody. Cells were analysed using a FACScan (Becton Dickinson). Black line, isotype control; red line, specific antibody stain. 
